Also trades as: 7741.T (JPX) · $vol 168M · HOCPY (OTC) · $vol 6M

$146.72

+0.00 (+0.00%)

OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 45 · $49.1B mcap · 334M float · 0.0000% daily turnover · Short 19% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$953.7B +7.7% ▲

5Y CAGR: +11.7%

Gross Profit

$753.4B -1.7% ▼

5Y CAGR: +9.7%

Operating Income

$282.2B -41.3% ▼

5Y CAGR: +1.4%

Net Income

$254.7B +26.0% ▲

5Y CAGR: +15.2%

EPS (Diluted)

$747.77 +28.6% ▲

5Y CAGR: +17.4%

EBITDA

$282.2B -9.0% ▼

5Y CAGR: +7.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$661.5B	$723.6B	$792.6B	$885.8B	$953.7B
YoY Growth	+20.7%	+9.4%	+9.5%	+11.8%	+7.7%
Cost of Revenue	$103.0B	$102.2B	$104.6B	$119.6B	$200.4B
Gross Profit	$567.3B	$631.9B	$688.0B	$766.3B	$753.4B
Gross Margin	85.8%	87.3%	86.8%	86.5%	79.0%
R&D Expenses	$25.4B	$29.4B	$0	$0	$229M
SG&A Expenses	$50.8B	$60.0B	$18.3B	$21.0B	$471.2B
Operating Expenses	$203.8B	$231.0B	$254.5B	$285.5B	$471.2B
Operating Income	$317.0B	$346.4B	$433.5B	$480.8B	$282.2B
Operating Margin	47.9%	47.9%	54.7%	54.3%	29.6%
Interest Expense	$1.7B	$1.8B	$1.9B	$1.5B	$2.0B
Income Before Tax	$210.7B	$215.8B	$236.6B	$260.0B	$329.7B
Tax Expense	$45.4B	$47.0B	$54.0B	$58.2B	$76.7B
Net Income	$164.5B	$168.6B	$181.4B	$202.1B	$254.7B
Net Margin	24.9%	23.3%	22.9%	22.8%	26.7%
EPS (Diluted)	$445.93	$469.47	$515.27	$581.26	$747.77
EBITDA	$255.4B	$267.3B	$285.7B	$310.0B	$282.2B
Shares Outstanding	369M	359M	352M	348M	340M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$231.2B	$214.7B	$221.4B	$218.5B	$220.9B	$237.8B	$244.9B	$249.7B
Cost of Revenue	$98.0B	$95.1B	$29.8B	$30.1B	$31.8B	$48.7B	$50.1B	$56.9B
Gross Profit	$115.8B	$119.6B	$191.6B	$188.4B	$189.1B	$189.2B	$194.8B	$192.8B
Gross Margin	50.1%	55.7%	86.5%	86.2%	85.6%	79.5%	79.5%	77.2%
R&D Expenses	$0	$0	$9.0B	$9.1B	$8.5B	$9.4B	$9.2B	$59M
SG&A Expenses	$19.1B	$18.3B	$72.6B	$71.6B	$70.7B	$110.9B	$112.6B	$118.7B
Operating Expenses	$19.1B	$18.3B	$81.6B	$80.8B	$79.1B	$120.2B	$121.8B	$118.7B
Operating Income	$161.8B	$101.3B	$110.0B	$107.7B	$109.9B	$69.0B	$73.0B	$74.1B
Operating Margin	70.0%	47.2%	49.7%	49.3%	49.8%	29.0%	29.8%	29.7%
Interest Expense	$331M	$0	$0	$3M	$3M	$507M	$497M	$509M
Income Before Tax	$64.2B	$62.8B	$65.2B	$67.7B	$67.4B	$73.0B	$110.9B	$78.1B
Tax Expense	$17.1B	$9.9B	$14.5B	$16.7B	$16.0B	$17.2B	$19.6B	$23.8B
Net Income	$47.2B	$52.9B	$50.5B	$51.5B	$51.8B	$56.2B	$91.7B	$54.6B
Net Margin	20.4%	24.7%	22.8%	23.6%	23.5%	23.6%	37.4%	21.9%
EPS (Diluted)	$134.62	$151.97	$145.32	$149.50	$151.22	$164.00	$270.74	$161.38
EBITDA	-$401M	$74.6B	$119.0B	$116.8B	$118.4B	$87.5B	$126.4B	$74.1B
Shares Outstanding	350M	348M	347M	345M	343M	342M	339M	337M

HOCPF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet